Find a Commonwealth Resource
Octreotide acetate
HealthData.Gov
Updated May 26, 2026
About this dataset
Sandostatin (octreotide acetate) is an injectable prescription medication manufactured by Novartis Pharmaceuticals Corporation. It acts as a somatostatin analog, administered intravenously or subcutaneously in various strengths to help regulate hormone levels. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Octreotide acetate
Access the FDA dataset for Octreotide acetate — ANDA 210317 submitted by Mylan Institutional LLC
Modified Mar 23, 2026